Literature DB >> 2509815

The salience of Garrod's 'molecular groupings' and 'Inborn Factors in Disease'.

C R Scriver1.   

Abstract

Garrod's important second book, Inborn Factors in Disease (1931), was about inherited predisposition to disease. Chemical and metabolic individuality, which are the modalities of predisposition, originated in 'molecular groupings' (proteins) in Garrod's view of life. Such 'groupings' as interlocus molecular hybrids, allelic complementation and expressions of modifier genes, can assume variant expression in heterozygotes. Here, it is shown that genetic variation in such 'molecular groupings' has clinical relevance, for example (1) in reproductive counselling for thalassaemia; (2) in heterozygosity where the affected enzymes are normally homopolymeric; (3) in clinical severity of 'monogenic' disease (e.g. familial hypercholesterolaemia and muscular dystrophy) when variation is not explained by allelic heterogeneity. The associated chemical individuality in each case can be used to identify risk and thus as a mode of predictive medicine.

Entities:  

Mesh:

Year:  1989        PMID: 2509815     DOI: 10.1007/bf01799283

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  50 in total

1.  Sir Archibald Garrod's conception of chemical individuality: a modern appreciation.

Authors:  B Childs
Journal:  N Engl J Med       Date:  1970-01-08       Impact factor: 91.245

Review 2.  A receptor-mediated pathway for cholesterol homeostasis.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

3.  The interaction of alpha thalassaemia with heterozygous beta thalassaemia.

Authors:  E Kanavakis; J S Wainscoat; W G Wood; D J Weatherall; A Cao; M Furbetta; R Galanello; D Georgiou; T Sophocleous
Journal:  Br J Haematol       Date:  1982-11       Impact factor: 6.998

4.  Metabolic interference and the + - heterozygote. a hypothetical form of simple inheritance which is neither dominant nor recessive.

Authors:  W G Johnson
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

Review 5.  Clinical consequences of heterozygosity for autosomal-recessive diseases.

Authors:  F Vogel
Journal:  Clin Genet       Date:  1984-05       Impact factor: 4.438

6.  Biosynthesis of tetrahydrobiopterin. Purification and characterization of 6-pyruvoyl-tetrahydropterin synthase from human liver.

Authors:  S Takikawa; H C Curtius; U Redweik; W Leimbacher; S Ghisla
Journal:  Eur J Biochem       Date:  1986-12-01

7.  Studies on the molecular defect in phenylketonuria and hyperphenylalaninaemia using antibodies against phenylalanine hydroxylase.

Authors:  K Bartholomé; A Dresel
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

8.  Hyperphenylalaninemia due to deficiency of 6-pyruvoyl tetrahydropterin synthase. Unusual gene dosage effect in heterozygotes.

Authors:  C R Scriver; C L Clow; P Kaplan; A Niederwieser
Journal:  Hum Genet       Date:  1987-10       Impact factor: 4.132

9.  Aspartylglucosaminuria: deficiency of aspartylglucosaminidase in cultured fibroblasts of patients and their heterozygous parents.

Authors:  P Aula; V Näntö; M L Laipio; S Autio
Journal:  Clin Genet       Date:  1973       Impact factor: 4.438

10.  Homozygous familial hypercholesterolemia among French Canadians in Québec Province.

Authors:  S Moorjani; M Roy; C Gagné; J Davignon; D Brun; M Toussaint; M Lambert; L Campeau; S Blaichman; P Lupien
Journal:  Arteriosclerosis       Date:  1989 Mar-Apr
View more
  4 in total

1.  A synopsis of the unconjugated acidic transamination metabolites of phenylalanine in phenylketonuria.

Authors:  U Langenbeck; A Behbehani; A Mench-Hoinowski
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

Review 2.  Garrod's foresight; our hindsight.

Authors:  C R Scriver
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

3.  Maternal Phenylketonuria Collaborative Study (MPKUCS)--the 'outliers'.

Authors:  W B Hanley; C Azen; R Koch; K Michals-Matalon; R Matalon; B Rouse; F Trefz; S Waisbren; F de la Cruz
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 4.  Does hereditary metabolic disease modulate senescence and ageing?

Authors:  C R Scriver
Journal:  J Inherit Metab Dis       Date:  2002-05       Impact factor: 4.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.